-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.00126.34% Upside
Aldeyra Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Aldeyra Therapeutics, Inc.?
Aldeyra Therapeutics, Inc. has been rated by research analysts at Oppenheimer, H.C. Wainwright in the past 90 days.